Wasatch Advisors Inc Cocrystal Pharma, Inc. Transaction History

Wasatch Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$0.48 - $2.19 $863,758 - $3.94 Million	-1,799,496 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.39 - $2.05 $252,238 - $1.33 Million	646,765 Added 56.11%	1,799,496 $899,000
Q2 2019 Aug 07, 2019	BUY	$2.06 - $2.75 $122,024 - $162,896	59,235 Added 5.42%	1,152,731 $0
Q1 2019 May 08, 2019	BUY	$2.65 - $4.14 $1.88 Million - $2.94 Million	710,112 Added 185.22%	1,093,496 $0
Q4 2018 Feb 14, 2019	SELL	$1.6 - $3.68 $132,014 - $303,633	-82,509 Reduced 17.71%	383,384 $1.38 Million
Q3 2018 Nov 07, 2018	SELL	$2.3 - $4.95 $92,048 - $198,103	-40,021 Reduced 7.91%	465,893 $0
Q2 2018 Aug 02, 2018	BUY	$1.79 - $6.25 $905,586 - $3.16 Million	505,914 New	505,914 $0

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $14.6M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Wasatch Advisors Inc with notifications on news.